Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Puma Biotechnology Inc - Common Stock
(NQ:
PBYI
)
5.675
-0.275 (-4.62%)
Streaming Delayed Price
Updated: 2:21 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Puma Biotechnology Inc - Common Stock
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 10, 2025
Via
Benzinga
Puma Biotechnology (NASDAQ:PBYI) Tops Q3 2025 Estimates and Raises Full-Year Outlook
↗
November 06, 2025
Puma Biotech's Q3 2025 earnings beat expectations, driven by strong NERLYNX sales. The company raised its full-year revenue guidance and advances its clinical pipeline.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Puma (PBYI) Q2 Revenue Rises 11%
↗
August 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 01, 2024
Via
Benzinga
Where Puma Biotechnology Stands With Analysts
↗
July 26, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
↗
June 04, 2024
Via
Benzinga
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
↗
May 20, 2024
A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.
Via
Benzinga
Topics
Intellectual Property
PBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024
↗
May 02, 2024
PBYI stock results show that Puma Biotechnology beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
↗
April 19, 2024
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
March 19, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
↗
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Earnings Scheduled For August 3, 2023
↗
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Why Shares of Puma Biotechnology Rose This Week
↗
December 15, 2022
The company's CEO bought $2.5 million worth of company stock.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 14, 2024
Via
Benzinga
3 Strong Buy Stocks Under $5: January 2024
↗
January 31, 2024
A strong buy rating carries weight which speculative investors may want to research in these strong buy stocks under $5.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 24, 2023
Via
Benzinga
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
↗
July 20, 2023
Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 20, 2023
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 05, 2023
Via
Benzinga
7 A-Rated Penny Stocks Worth Betting On
↗
February 19, 2023
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
↗
December 26, 2022
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 25, 2022
Via
Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via
Benzinga
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
↗
November 28, 2022
Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.
Via
Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
↗
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
